IOVA 8-K 2026-10-05

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) 8-K dated 2026-10-05 — accession 0001104659-26-113763. This URL is the filing, not the IOVA hub.

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) is a biotechnology company listed on US.

IOVANCE BIOTHERAPEUTICS, INC. filed a 8-K on 2026-10-05. Accession 0001104659-26-113763.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IOVA revenue for 2025-12-31 was $263.5M. Net income was -$391.0M. Revenue was up 60.6% from 2024-12-31 to 2025-12-31. IOVA currently screens at market cap $1.89B.

Not investment advice. The IOVA SEC hub lists recent forms. The stock page is the research view.